SCHEMBL2802383

SCHEMBL2802383

CCS(=O)(=O)NC(=O)c1cnn2c(Nc3ccccc3OC)c(C(=O)N3CCC(c4ccccc4)CC3)cnc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.45
CASP1 P29466 1/20 0.44
ALDH1A1 P00352 3/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
NPSR1 Q6W5P4 2/20 0.41
MAPT P10636 1/20 0.41
PIM1 P11309 1/20 0.41
LIMK1 P53667 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
KDM4E B2RXH2 1/20 0.40
TYK2 P29597 1/20 0.40
STAT3 P40763 1/20 0.40
GAA P10253 1/20 0.40
CNR2 P34972 1/20 0.39
CCR5 P51681 1/20 0.39
ACHE P22303 1/20 0.38
BACE1 P56817 1/20 0.38
TP53 P04637 1/20 0.37
EGFR P00533 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2801506 0.92 MGLL (0.38) HPGDCASP1ALDH1A1L3MBTL1NPSR1
SCHEMBL2803258 0.91 MAP3K7 (0.38) HPGDCASP1ALDH1A1L3MBTL1NPSR1
SCHEMBL2801510 0.90 EGLN1 (0.38) ALDH1A1L3MBTL1PIM1
SCHEMBL2803213 0.90 NPC1 (0.40) ALDH1A1L3MBTL1KMT2ATP53
SCHEMBL2800478 0.89 SIRT5 (0.46) HPGDALDH1A1MAPTGAACNR2
SCHEMBL2798467 0.89 ALDH1A1 (0.51) HPGDCASP1ALDH1A1L3MBTL1NPSR1
SCHEMBL2803776 0.88 SPR (0.38) ALDH1A1L3MBTL1KMT2AKDM4E
SCHEMBL2802343 0.88 JAK2 (0.38) ALDH1A1L3MBTL1TYK2
SCHEMBL2798787 0.88 TNF (0.36) ALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL2801637 0.87 SIRT5 (0.41) ALDH1A1MAPTGAATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2206714-B1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO LTD (JP) 2015-01-21 EP disclosed
US-8729264-B2 Agent for prevention and/or treatment of skin diseases KYOWA HAKKO KIRIN CO., LTD. (JP) 2014-05-20 US disclosed
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-10-07 US disclosed
EP-2206714-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES Kyowa Hakko Kirin Co., Ltd. (JP) 2010-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES TYR, CUTA, SERPINB1 HPGD 589/4885CASP1 561/4885ALDH1A1 243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.